Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

Automation in Talent Attraction: fighting candidate pre-conditioning.

How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...

Nobias Therapeutics Appoints Patrick Dougherty as CEO to Lead Next Phase of Growth

Philadelphia, November 14, 2024 (PRNewswire) -- Nobias Therapeutics has named Patrick Dougherty as its Chief Executive Officer, marking...

Metsera Secures $215M in Series B Funding to Advance Obesity and Metabolic Disease Portfolio

New York, November 13, 2024 (Business Wire) -- Metsera has raised $215 million in Series B financing, led by Wellington Management and...

Julie Eastland Appointed CEO of Zentalis Pharmaceuticals to Lead Advancement of Azenosertib in Oncology

San Diego, CA, November 13, 2024 (Globe Newswire) -- Zentalis Pharmaceuticals has appointed Julie Eastland as CEO, supported by Ingmar...

Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio

Marlborough, MA, November 15, 2024 (PRNewswire) -- Boston Scientific has acquired Axonics for $3.7 billion, expanding its Urology...

Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline

Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for...

Celltex Therapeutics Welcomes Anita Perry as CEO

Houston, TX, November 5, 2024 (PRNewswire) -- Celltex Therapeutics appointed Anita Perry as CEO following the retirement of Co-Founder...

Alpha-9 Oncology Secures $175M Series C to Drive Radiopharmaceutical Innovation in Cancer Treatment

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to...

I-Mab Appoints Dr. Sean Fu as Permanent CEO to Lead Advancement of Cancer Immunotherapy Programs

Rockville, MD, November 6, 2024 (PRNewswire) -- I-Mab has named Dr. Sean Fu as its CEO to drive forward its cancer immunotherapy...

AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio

North Chicago, IL, October 28, 2024 (Reuters) -- AbbVie will acquire Aliada Therapeutics for $1.4 billion to gain access to an...

Terray Therapeutics Secures $120M in Series B Funding to Revolutionize Small Molecule Drug Development with Advanced AI

Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to...

ViaNautis Bio Appoints Dr. Adi Hoess as CEO to Propel Growth in Genetic Therapies

Cambridge, UK, October 18, 2024 ( GlobeNewswire ) -- ViaNautis Bio has appointed Dr. Adi Hoess as its new Chief Executive Officer,...

AvenCell Therapeutics Secures $112M in Series B Funding to Advance Innovative Switchable CAR-T Cell Therapies

Watertown, MA, October 22, 2024 (PRNewswire) -- AvenCell Therapeutics has secured $112 million in Series B funding to enhance its...